Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse.
about
Recent advances in the genetics of schizophreniaUp-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patientsGenetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophreniaReduced dendritic spine density in auditory cortex of subjects with schizophreniaThe suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disordersReplicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injuryAuditory dysfunction in schizophrenia: integrating clinical and basic features.Better understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse modelsGene expression profiling of the brain: pondering facts and fictionDevelopment of sensory gamma oscillations and cross-frequency coupling from childhood to early adulthoodErythropoietin: a candidate compound for neuroprotection in schizophreniaMolecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disordersMolecular genetic studies of schizophreniaMechanisms of lead and manganese neurotoxicityThe post-synaptic density of human postmortem brain tissues: an experimental study paradigm for neuropsychiatric illnessesFunctional consequences of hippocampal neuronal ectopia in the apolipoprotein E receptor-2 knockout mouseDisrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergenceAntipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotectionStrain- and region-specific gene expression profiles in mouse brain in response to chronic nicotine treatment.Deficiency of schnurri-2, an MHC enhancer binding protein, induces mild chronic inflammation in the brain and confers molecular, neuronal, and behavioral phenotypes related to schizophrenia.Preweaning sensorimotor deficits and adolescent hypersociability in Grin1 knockdown mice.Models of neurodevelopmental abnormalities in schizophrenia.Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.Post hoc pattern matching: assigning significance to statistically defined expression patterns in single channel microarray data.Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs.Gene expression profiling of neurochemically defined regions of the human brain by in situ hybridization-guided laser capture microdissectionExon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation.Expression of the Rap1 guanine nucleotide exchange factor, MR-GEF, is altered in individuals with bipolar disorder.NMDA receptor hypofunction induces dysfunctions of energy metabolism and semaphorin signaling in rats: a synaptic proteome study.Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's modelsThe DTNBP1 (dysbindin-1) gene variant rs2619522 is associated with variation of hippocampal and prefrontal grey matter volumes in humans.Postnatal developmental trajectories of neural circuits in the primate prefrontal cortex: identifying sensitive periods for vulnerability to schizophrenia.Postnatal expression profile of OBCAM implies its involvement in visual cortex development and plasticity.Prefrontal inefficiency is associated with polygenic risk for schizophreniaDifferential functional constraints on the evolution of postsynaptic density proteins in neocortical laminae.Analyzing schizophrenia by DNA microarraysLack of change in markers of presynaptic terminal abundance alongside subtle reductions in markers of presynaptic terminal plasticity in prefrontal cortex of schizophrenia patients.Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia.Human postmortem tissue: what quality markers matter?
P2860
Q22242872-53F8BC3F-DC69-410A-8258-7ED7F502EAB3Q24541308-6B580F9B-B6CC-4477-AB15-92B33AB65D26Q24612644-084E7658-4B9F-4ADB-B69A-16A30CFBBF7FQ24658134-3EBFE684-DEBB-46FC-86AB-F0EF0C70325CQ24682931-02E820D2-591A-4C27-AD0F-143146506555Q24794310-DEF1A7ED-278B-4C2B-8DD6-4900ECC1DAA1Q26796401-A86E8B2E-6164-4F8F-97FB-02AC40C6B9A4Q26866254-F6B9DA60-22AC-431A-8069-F8493706D237Q27010353-AF24A2A5-E73B-4FD5-92AF-D17D75F4DC99Q27303073-B98CE3C1-B6A7-4BA0-8B58-E9765B17B3CCQ28212816-87A46D49-F23F-4462-80CD-18D0ED195F12Q28240591-924F79CD-32B9-4B5E-897B-7096E33A6515Q28242041-3C246844-7D87-47EC-BED9-42AE5B1F709BQ28388379-95F83043-183D-4A75-9547-A357AF7F2F79Q28475295-B1D8C411-D2EA-4767-9B55-B1B8DFC6380DQ28509242-2D5C72DB-D269-4096-8497-40857412BFE0Q28583457-D6A9D4C2-C5CD-4B25-8D33-0BA24F090F0CQ29618819-8EDB1AF9-7A6D-42D0-870B-A555883F7461Q30386608-1C912739-4238-4815-AFEB-EBE2C6BAD333Q30443645-263FCC86-2761-4ACE-B545-1F66E4162D93Q30453022-C26D3192-1ABD-4BC1-9B1A-FC277FC96DA3Q30454766-8A537B03-71A3-466D-AAE4-DE04A27870F0Q30457462-2AEB636C-4141-4181-A412-F6EC7BD9164AQ30459497-999BFCA4-4210-46D7-B012-27F7B084661EQ31117853-D259CC1B-5BB3-4F68-98F3-3424D7EE3E22Q33260941-324A01AB-57C4-4C27-A9FB-65EF69C82203Q33391810-AC87AEFF-CBC9-41FB-9CF4-7A40B30FD34EQ33505860-7337BC29-63E4-43AA-9334-431FB9723A12Q33570567-29B0449F-D8E2-423D-939C-1BCA93FCDA4EQ33749231-98671FFD-0D91-426F-AF2A-9850D83B4D99Q33947378-50BCFAC9-25F9-4945-AC54-0C1FF29AEDE4Q34031938-8AC85799-C9BB-472B-8114-11D815707C60Q34179419-6A4D712D-35F9-46DC-8938-CE4D1E629366Q34313653-33A7430B-82B9-40F2-9025-5AE3A9D26FE0Q34322910-084CE4E2-4C58-4C35-B303-329107C2D40AQ34326447-289C7039-FE41-47A6-870A-97F4D73F388DQ34367499-7091D2C8-1F6C-4AC3-A036-9CFFB19638F5Q34404767-52C66094-7CD4-4D53-A79D-36B1D6ABF0DCQ34452249-76BBD509-975E-4CBB-908D-B0833BAE4612Q34574442-FDBE151E-6A2A-4670-9612-45352F543D7D
P2860
Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Analysis of complex brain diso ...... a as a disease of the synapse.
@ast
Analysis of complex brain diso ...... a as a disease of the synapse.
@en
Analysis of complex brain diso ...... a as a disease of the synapse.
@nl
type
label
Analysis of complex brain diso ...... a as a disease of the synapse.
@ast
Analysis of complex brain diso ...... a as a disease of the synapse.
@en
Analysis of complex brain diso ...... a as a disease of the synapse.
@nl
prefLabel
Analysis of complex brain diso ...... a as a disease of the synapse.
@ast
Analysis of complex brain diso ...... a as a disease of the synapse.
@en
Analysis of complex brain diso ...... a as a disease of the synapse.
@nl
P2093
P1476
Analysis of complex brain diso ...... a as a disease of the synapse.
@en
P2093
P304
P356
10.1016/S0166-2236(00)01862-2
P577
2001-08-01T00:00:00Z